Kayne Anderson Rudnick Investment Management
IBB icon

Kayne Anderson Rudnick Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Sell
3,085
-268
-8% -$46.1K ﹤0.01% 470
2026
Q1 		$566K Sell
3,353
-312
-9% -$53.4K ﹤0.01% 425
2025
Q4 		$619K Sell
3,665
-210
-5% -$34.1K ﹤0.01% 430
2025
Q3 		$559K Sell
3,875
-1,329
-26% -$181K ﹤0.01% 433
2025
Q2 		$659K Hold
5,204
– – ﹤0.01% 409
2025
Q1 		$666K Sell
5,204
-960
-16% -$130K ﹤0.01% 407
2024
Q4 		$815K Sell
6,164
-549
-8% -$77.2K ﹤0.01% 396
2024
Q3 		$977K Sell
6,713
-507
-7% -$73.4K ﹤0.01% 386
2024
Q2 		$991K Sell
7,220
-67
-0.9% -$8.94K ﹤0.01% 392
2024
Q1 		$1M Sell
7,287
-366
-5% -$50K ﹤0.01% 365
2023
Q4 		$1.04M Sell
7,653
-421
-5% -$51.4K ﹤0.01% 362
2023
Q3 		$988K Sell
8,074
-255
-3% -$32.4K ﹤0.01% 365
2023
Q2 		$1.06M Sell
8,329
-611
-7% -$79.4K ﹤0.01% 361
2023
Q1 		$1.16M Sell
8,940
-209
-2% -$27.4K ﹤0.01% 348
2022
Q4 		$1.2M Sell
9,149
-533
-6% -$68.9K ﹤0.01% 355
2022
Q3 		$1.13M Buy
9,682
+6
+0.1% +$745 ﹤0.01% 345
2022
Q2 		$1.14M Sell
9,676
-129
-1% -$15.3K ﹤0.01% 341
2022
Q1 		$1.28M Sell
9,805
-164
-2% -$21.4K ﹤0.01% 330
2021
Q4 		$1.52M Buy
9,969
+147
+1% +$22.8K ﹤0.01% 329
2021
Q3 		$1.59M Sell
9,822
-724
-7% -$122K ﹤0.01% 311
2021
Q2 		$1.73M Sell
10,546
-622
-6% -$95.8K ﹤0.01% 304
2021
Q1 		$1.68M Buy
11,168
+354
+3% +$56.2K ﹤0.01% 299
2020
Q4 		$1.64M Buy
10,814
+36
+0.3% +$5.14K ﹤0.01% 298
2020
Q3 		$1.46M Sell
10,778
-210
-2% -$28.5K 0.01% 293
2020
Q2 		$1.5M Sell
10,988
-703
-6% -$89.6K 0.01% 293
2020
Q1 		$1.26M Sell
11,691
-224
-2% -$25.8K 0.01% 285
2019
Q4 		$1.44M Sell
11,915
-1,011
-8% -$113K 0.01% 290
2019
Q3 		$1.29M Sell
12,926
-717
-5% -$75.1K 0.01% 285
2019
Q2 		$1.49M Sell
13,643
-364
-3% -$38.7K 0.01% 277
2019
Q1 		$1.57M Sell
14,007
-45
-0.3% -$4.94K 0.01% 264
2018
Q4 		$1.36M Sell
14,052
-1,132
-7% -$120K 0.01% 274
2018
Q3 		$1.85M Sell
15,184
-1,007
-6% -$119K 0.01% 259
2018
Q2 		$1.78M Buy
16,191
+566
+4% +$60.5K 0.01% 264
2018
Q1 		$1.67M Buy
15,625
+750
+5% +$83.1K 0.01% 275
2017
Q4 		$1.59M Buy
14,875
+322
+2% +$34.4K 0.01% 271
2017
Q3 		$1.62M Buy
14,553
+459
+3% +$49.1K 0.01% 277
2017
Q2 		$1.46M Sell
14,094
-813
-5% -$80.1K 0.01% 274
2017
Q1 		$1.46M Buy
14,907
+408
+3% +$39.1K 0.02% 276
2016
Q4 		$1.28M Sell
14,499
-1,023
-7% -$93.1K 0.02% 274
2016
Q3 		$1.5M Sell
15,522
-327
-2% -$31.1K 0.02% 265
2016
Q2 		$1.36M Sell
15,849
-159
-1% -$14.3K 0.02% 262
2016
Q1 		$1.39M Sell
16,008
-231
-1% -$20.7K 0.02% 251
2015
Q4 		$1.83M Sell
16,239
-309
-2% -$33.5K 0.03% 227
2015
Q3 		$1.67M Sell
16,548
-2,244
-12% -$269K 0.03% 221
2015
Q2 		$2.31M Buy
18,792
+1,002
+6% +$120K 0.04% 205
2015
Q1 		$2.04M Buy
17,790
+1,866
+12% +$206K 0.03% 207
2014
Q4 		$1.61M Buy
15,924
+1,728
+12% +$168K 0.03% 226
2014
Q3 		$1.29M Sell
14,196
-531
-4% -$46.6K 0.02% 234
2014
Q2 		$1.26M Buy
14,727
+480
+3% +$37.8K 0.02% 228
2014
Q1 		$1.12M Sell
14,247
-660
-4% -$55K 0.02% 232
2013
Q4 		$1.13M Buy
14,907
+405
+3% +$28.7K 0.02% 224
2013
Q3 		$1.01M Hold
14,502
– – 0.02% 218
2013
Q2 		$840K Buy
+14,502
New +$838K 0.02% 219

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's IBB Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 8% in Q2 2026, selling an estimated $46.1K and leaving 3,085 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Kayne Anderson Rudnick Investment Management first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.31M in Q2 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 3,085 shares of iShares Biotechnology ETF worth $587K as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 268 iShares Biotechnology ETF shares in Q2 2026, an estimated $46.1K.
  • iShares Biotechnology ETF made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #470 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • Kayne Anderson Rudnick Investment Management's iShares Biotechnology ETF position peaked at $2.31M in Q2 2015.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.